IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6)

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2393-2400

  Huffnagle, Gary B ^a,d   Boyd, Michael B ^a   Street, Nancy E ^b   Lipscomb, Mary F ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 5; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HELPER CELL; HOST RESISTANCE; INFLAMMATORY INFILTRATE; LOEFFLER PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE DEPLETION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHRONIC DISEASE; CRYPTOCOCCOSIS; CRYSTALLIZATION; DISEASE SUSCEPTIBILITY; EOSINOPHILIA; EOSINOPHILS; FEMALE; GLYCOPROTEINS; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG DISEASES, FUNGAL; LYSOPHOSPHOLIPASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA;

EID: 0032032243     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Allen, J. N., and W. B. Davis. 1994. Eosinophilic lung diseases. Am. J. Respir. Crit. Care Med. 150:1423.
2. Echols, R. M., D. L. Palmer, and G. W. Long. 1982. Tissue eosinophilia in human coccidioidomycosis. Rev. Infect. Dis. 4:656.
3. Lombard, C. M., H. D. Tazelaar, and D. L. Krasne. 1987. Pulmonary eosinophilia in coccidioidal infections. Chest 91:734.
4. Marwaha, R. K., A. Trehan, K. Jayashree, and R. K. Vasishta. 1995. Hypereosinophilia in disseminated cryptococcal disease. Pediatr. Infect. Dis. J. 14:1102.
5. Starr, J. C., H. Che, and J. Montgomery. 1995. Cryptococcal pneumonia simulating chronic eosinophilic pneumonia. South. Med. J. 88:845.
6. Tanaka, H., F. Urase, H. Hasegawa, K. Tsubaki, K. Irimajiri, and A. Horiuchi. 1988. Sarcoidosis with severe eosinophilia due to cryptococcus infection. Rinsho Ketsueki 29:208.
7. Ando, M., M. Suga, Y. Nishiura, and M. Miyajima. 1995. Summer-type hypersensitivity pneumonitis. Intern. Med. 34:707.
8. Miyagawa, T., S. Hamagami, T. Ochi, T. Osugi, M. Kikui, and H. Takahashi. 1982. Japanese summer-type hypersensitivity pneumonitis: studies using Cryptococcus antigen. Clin. Allergy 12:343.
9. Diamond, R. D. 1995. Cryptococcus neoformans. In Principles and Practice of Infectious Diseases. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, p. 2331.
10. + T cells. J. Exp. Med. 173:793.
11. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423.
12. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487.
13. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated immunity and pulmonary inflammation by a high melanin-producing strain of C. neoformans. J. Immunol. 155:3507.
14. Feldmesser, M., A. Casadevall, Y. Kress, G. Spira, and A. Orlofsky. 1997. Eosinophil-Cryptococcus interactions in vivo and in vitro. Infect. Immun. 65:1899.
15. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
16. Lovchik, J., M. Lipscomb, and C. R. Lyons. 1997. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J. Immunol. 158:1772.
17. + T cells. J. Exp. Med. 173:755.
18. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685.
19. Huffnagle, G. B., and M. F. Lipscomb. 1992. Animal model of human disease: pulmonary cryptococcosis. Am. J. Pathol. 141:1517.
20. Lovchik, J. A., C. R. Lyons, and M. F. Lipscomb. 1995. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:116.
21. Huffnagle, G. B., R. M. Stricter, R. A. McDonald, L. K. McNeil, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1997. Efferent phase production of macrophage inflammatory protein-1α (MIP-1α) is required for protective cell-mediated immunity to a pulmonary Cryptococcus neoformans infection. J. Immunol. 159:318.
22. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Stricter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529.
23. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155: 4790.
24. Kawakami, K., X. Qifeng, M. Tohyama, M. H. Qureshi, and A. Saito. 1996. Contribution of tumor necrosis factor-alpha in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 106:468.
25. Kawakami, K., M. Tohyama, Q. Xie, and A. Saito. 1996. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208.
26. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor alpha and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725.
27. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447.
28. Sanderson, C. J. 1994. Interleukin-5. In The Cytokine Handbook. A. Thomson, ed. Academic Press, New York, p. 127.
29. Murali, P. S., A. Kumar, H. Choi, N. K. Banasal, J. N. Fink, and V. P. Kurup. 1993. Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J. Leukocyte Biol. 53:264.
30. el-Hashimi, W. 1971. Charcot-Leyden crystals: formation from primate and lack of formation from nonprimate eosinophils. Am. J. Pathol. 65:311.
31. Dvorak, A. M., P. F. Weller, R. A. Monahan-Earley, L. Letourneau, and S. J. Ackerman. 1990. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab. Invest. 62: 590.
32. Weller, P. F., E. J. Goetzl, and K. F. Austen. 1980. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc. Natl. Acad. Sci. USA 77:7440.
33. Dyer, K. D., J. S. Handen, and H. F. Rosenberg. 1997. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes. Genomics 40:217.
34. Ackerman, S. J., S. E. Corrette, H. F. Rosenberg, J. C. Bennett, D. M. Mastrianni, A. Nicholson-Weller, P. F. Weller, D. T. Chin, and D. G. Tenen. 1993. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase): similarities to IgE binding proteins and the S-type animal lectin superfamily. J. Immunol. 150:456.
35. Leonidas, D. D., B. L. Elbert, Z. Zhou, H. Leffler, S. J. Ackerman, and K. R. Acharya. 1995. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure 3:1379.
36. Dvorak, A. M., T. Furitsu, L. Letourneau, T. Ishizaka, and S. J. Ackerman. 1991. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am. J. Pathol. 138:69.
37. Abbas, A., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
38. Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 158:790.
39. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
40. Buchanan, K. L., and J. W. Murphy. 1993. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:2854.
41. Zhou, Z., D. G. Tenen, A. M. Dvorak, and S. J. Ackerman. 1992. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells. J. Leukocyte Biol. 52:588.
42. Calafat, J., H. Janssen, E. F. Knol, P. F. Weller, and A. Egesten. 1997. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils. Eur. J. Haematol. 58:56.
43. Curtis, J. L., G. B. Huffnagle, G. H. Chen, M. L. Warnock, M. R. Gyetko, R. A. McDonald, P. J. Scott, and G. B. Toews. 1994. Experimental murine pulmonary cryptococcosis: differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest. 71:113.
44. Costa, J. J., K. Matossian, M. B. Resnick, W. J. Beil, D. T. Wong, J. R. Gordon, A. M. Dvorak, P. F. Weller, and S. J. Galli. 1993. Human eosinophils can express the cytokines tumor necrosis factor-α and macrophage inflammatory protein-1α. J. Clin. Invest. 91:2673.
45. Hoag, K. A., M. F. Lipscomb, A. A. Izzo, and N. E. Street. 1998. IL-2 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17:733.
46. Hudson, G. 1968. Crystalloid material in macrophages of mouse bone marrow. Acta Anat. 71:100.
47. Ali, B. A. J. R. Shortland, and G. Hudson. 1981. Origin of crystalloid inclusions in macrophages II: evidence for derivation from eosinophil granulocyte breakdown. Br. J. Exp. Pathol. 62:662.
48. Ward, J. M. 1978. Pulmonary pathology of the motheaten mouse. Vet. Pathol. 15:170.
49. Murray, A. B., and A. Luz. 1990. Acidophilic macrophage pneumonia in laboratory mice. Vet. Pathol. 27:274.